About: Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2001 (uk) article scientifique publié en 2001 (fr) im Juli 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2001 (ast) scientific article published on 01 July 2001 (en)
publication date	wds:Q74139314-08058FD0-1F78-4CE1-8828-4D63025FFC42
publication date	2001-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74139314-EFA79AD2-6A08-463E-A688-D015A274578C
language of work or name	English
author name string	wds:Q74139314-3C7F12B0-06B6-4727-AAAD-3E00B438FEAE wds:Q74139314-4673E289-A641-47A6-928B-16CA2C7387EC wds:Q74139314-58C3456B-07FF-488B-94BD-41309B57DA26 wds:Q74139314-78CEE2BA-D7AA-4767-B824-3A7B10B64507 wds:Q74139314-907F3A1D-8A29-4D43-B932-6954797347BD wds:Q74139314-C22C8060-D7D2-4645-8528-C2A1F614C359 wds:Q74139314-DA283B1C-98CB-4803-94C1-037523B56890 wds:Q74139314-E02393B9-3FE2-4526-8331-C635A7EEC817
author name string	J C Meijers P G De Groot H L Janssen H K Nieuwenhuis B N Bouma F W Leebeek L O Mosnier T Lisman
rdfs:label	Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis (en) Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis (nl)
skos:prefLabel	Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis (en) Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis (nl)
name	Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis (en) Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis (nl)
title	wds:Q74139314-2BDE3B09-5CDE-4BC3-84C4-DD510FAE0D08
title	Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis (en)
page(s)	wds:Q74139314-5A13DF6D-1A0D-4B5A-8F9F-8617BBEC7148
page(s)	131-139
instance of	wds:Q74139314-B2D7CB92-34FE-4ADB-8608-B0839A5BF8EC
instance of	scholarly article
PubMed ID	wds:Q74139314-C6950D9B-BCB8-4FAA-B056-3B1A848F26DA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11438502
PubMed ID	11438502
published in	wds:Q74139314-8BB3657C-8130-445A-BE87-04DC0657F3E0
published in	Gastroenterology
issue	wds:Q74139314-4180E655-730A-4C95-9ECD-BBDC0F95A021
volume	wds:Q74139314-2BA70008-FC84-4C5F-AEF1-A432BCE9CA71
issue	1
volume	121
DOI	wds:Q74139314-4C533265-53CF-438F-910B-749DCDBAA307
DOI	http://dx.doi.org/10.1053/GAST.2001.25481
DOI	10.1053/GAST.2001.25481
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74139314
is cites work of	New insights into the coagulopathy of liver disease and liver transplantation Haemostatic abnormalities in patients with liver disease Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management Plasma clot lysis time and its association with cardiovascular risk factors in black Africans Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study Monitoring coagulation proteins during progression of liver disease Liver disease, coagulopathies and transfusion therapy Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most? Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference Perioperative thromboprophylaxis in liver transplant patients Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis How to minimize blood loss during liver surgery in patients with cirrhosis Coagulopathy and transfusion therapy in pediatric liver transplantation Coagulopathy in liver disease: Lack of an assessment tool Changing Concepts of Cirrhotic Coagulopathy The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis Effect of enoxaparin on plasma fibrin clot properties and fibrin structure in patients with acute pulmonary embolism Venous thromboembolism in cirrhosis Venous thromboembolism in cirrhosis: a review of the literature Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? Procoagulant therapeutics in liver disease: a critique and clinical rationale. The coagulopathy of cirrhosis: Myth or reality? Bleeding related to disturbed fibrinolysis Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model. Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity. Viral cirrhosis: an overview of haemostatic alterations and clinical consequences Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases Haemostatic alterations in cirrhotic patients: from primary haemostasis to fibrinolysis Development and application of global assays of hyper- and hypofibrinolysis Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival Management of hemostasis abnormalities in patients with liver failure Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trial Determinants of hypofibrinolysis in patients with digestive tract cancer Fibrinolytic Activity of Blood and its Determinants in Healthy Medical Students Thrombin-activatable Fibrinolysis Inhibitor (TAFI) as a Novel Prognostic Factor After Orthotropic Liver Transplantation: A Pilot Study. Acute kidney injury in decompensated cirrhosis is associated with both hypo- and hyper-coagulable features Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software